These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 37056863)

  • 21. Expression profile of epithelial-mesenchymal transition-related genes as a prognostic biomarker for endometrial cancer.
    Ye L; Wang X; Li B
    J Cancer; 2021; 12(21):6484-6496. PubMed ID: 34659539
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K/AKT pathway in bladder cancer.
    Chi M; Liu J; Mei C; Shi Y; Liu N; Jiang X; Liu C; Xue N; Hong H; Xie J; Sun X; Yin B; Meng X; Wang B
    J Exp Clin Cancer Res; 2022 May; 41(1):175. PubMed ID: 35581606
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development and Validation of a Novel Gene Signature for Predicting the Prognosis of Idiopathic Pulmonary Fibrosis Based on Three Epithelial-Mesenchymal Transition and Immune-Related Genes.
    Zheng J; Dong H; Zhang T; Ning J; Xu Y; Cai C
    Front Genet; 2022; 13():865052. PubMed ID: 35559024
    [No Abstract]   [Full Text] [Related]  

  • 24. A novel strategy to identify candidate diagnostic and prognostic biomarkers for gastric cancer.
    Liu L; Pang H; He Q; Pan B; Sun X; Shan J; Wu L; Wu K; Yao X; Guo Y
    Cancer Cell Int; 2021 Jul; 21(1):335. PubMed ID: 34215253
    [TBL] [Abstract][Full Text] [Related]  

  • 25. COL1A1 is a prognostic biomarker and correlated with immune infiltrates in lung cancer.
    Geng Q; Shen Z; Li L; Zhao J
    PeerJ; 2021; 9():e11145. PubMed ID: 33850663
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Construction of mRNA prognosis signature associated with differentially expressed genes in early stage of stomach adenocarcinomas based on TCGA and GEO datasets.
    Jiang F; Lin H; Yan H; Sun X; Yang J; Dong M
    Eur J Med Res; 2022 Oct; 27(1):205. PubMed ID: 36253873
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An
    Han Y; Wong FC; Wang D; Kahlert C
    Cancer Inform; 2022; 21():11769351221100727. PubMed ID: 35645555
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic Prediction Using a Stemness Index-Related Signature in a Cohort of Gastric Cancer.
    Chen X; Zhang D; Jiang F; Shen Y; Li X; Hu X; Wei P; Shen X
    Front Mol Biosci; 2020; 7():570702. PubMed ID: 33134315
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identifying
    Ding J; Liu Y; Lai Y
    PeerJ; 2020; 8():e10419. PubMed ID: 33282565
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of Stemness Characteristics Associated With the Immune Microenvironment and Prognosis in Gastric Cancer.
    Mao D; Zhou Z; Song S; Li D; He Y; Wei Z; Zhang C
    Front Oncol; 2021; 11():626961. PubMed ID: 33747944
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A nomogram model based on the number of examined lymph nodes-related signature to predict prognosis and guide clinical therapy in gastric cancer.
    Li H; Lin D; Yu Z; Li H; Zhao S; Hainisayimu T; Liu L; Wang K
    Front Immunol; 2022; 13():947802. PubMed ID: 36405735
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of a Four-Gene-Based SERM Signature for Prognostic and Drug Sensitivity Prediction in Gastric Cancer.
    Jia X; Chen B; Li Z; Huang S; Chen S; Zhou R; Feng W; Zhu H; Zhu X
    Front Oncol; 2021; 11():799223. PubMed ID: 35096599
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The prognostic value of circular RNA regulatory genes in competitive endogenous RNA network in gastric cancer.
    Han T; Chen Z; Chen W; Yuan L; Liu B
    Cancer Gene Ther; 2021 Nov; 28(10-11):1175-1187. PubMed ID: 33514881
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of the collagen family as prognostic biomarkers and immune-associated targets in gastric cancer.
    Chen Y; Chen W; Dai X; Zhang C; Zhang Q; Lu J
    Int Immunopharmacol; 2020 Oct; 87():106798. PubMed ID: 32693357
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Co-expression network analysis identified CDH11 in association with progression and prognosis in gastric cancer.
    Chen PF; Wang F; Nie JY; Feng JR; Liu J; Zhou R; Wang HL; Zhao Q
    Onco Targets Ther; 2018; 11():6425-6436. PubMed ID: 30323620
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of Potential Diagnostic and Prognostic Biomarkers for Gastric Cancer Based on Bioinformatic Analysis.
    Niu X; Ren L; Hu A; Zhang S; Qi H
    Front Genet; 2022; 13():862105. PubMed ID: 35368700
    [No Abstract]   [Full Text] [Related]  

  • 37. A novel pyroptosis gene expression-based risk score for survival in gastric cancer.
    Hu J; Song Y; Cai X; Halina H; Qiao K; Lu J; Yin C; Gao F
    Front Endocrinol (Lausanne); 2023; 14():1120216. PubMed ID: 36793271
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel epithelial-mesenchymal transition (EMT)-related gene signature of predictive value for the survival outcomes in lung adenocarcinoma.
    Cui Y; Wang X; Zhang L; Liu W; Ning J; Gu R; Cui Y; Cai L; Xing Y
    Front Oncol; 2022; 12():974614. PubMed ID: 36185284
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comprehensive evaluation of FKBP10 expression and its prognostic potential in gastric cancer.
    Liang L; Zhao K; Zhu JH; Chen G; Qin XG; Chen JQ
    Oncol Rep; 2019 Aug; 42(2):615-628. PubMed ID: 31233188
    [TBL] [Abstract][Full Text] [Related]  

  • 40. miR-133b Suppresses Invasion and Migration of Gastric Cancer Cells via the COL1A1/TGF-β Axis.
    Guo Y; Lu G; Mao H; Zhou S; Tong X; Wu J; Sun Q; Xu H; Fang F
    Onco Targets Ther; 2020; 13():7985-7995. PubMed ID: 32884288
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.